Ocular Manifestations in Rheumatic Diseases
Prevalence of Ocular Manifestations in Inflammatory Rheumatic Diseases
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Listed as NCT03753893, this observational or N/A phase trial focuses on Amaurosis Fugax and Blindness and remains completed. Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Apr 2025 — Present [monthly]
Completed
-
Jan 2025 — Apr 2025 [monthly]
Completed
-
Sep 2024 — Jan 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2022 — Jul 2024 [monthly]
Completed
Status: Unknown Status → Completed
▶ Show 4 earlier versions
-
Mar 2022 — May 2022 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Mar 2022 [monthly]
Active Not Recruiting
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting
-
Dec 2018 — Mar 2020 [monthly]
Active Not Recruiting
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.